文献速递垂体与肾上腺疾病

18F-FDG PET/CT 在非癌症患者肾上腺肿块定性中的表现:一项前瞻性研究

Performance of 18F-FDG PET/CT in the Characterization of Adrenal Masses in Noncancer Patients: A Prospective Study.
PubMed 文献 · J Clin Endocrinol Metab · 2017-01-01

这项前瞻性多中心研究纳入87例非癌症患者的87个肾上腺肿块,评估18F-FDG PET/CT诊断恶性肿瘤的表现,以病理为金标准、无病理者依据12个月影像随访。恶性肿块18F-FDG摄取参数更高,肿瘤SUVmax与肝脏SUVmax比值>1.5时灵敏度86.7%、特异度86.1%、准确率86.2%。作者认为18F-FDG PET/CT可补充肾上腺洗脱CT,应推荐用于大和/或性质未定肾上腺肿块的评估。

要点

  • 在非癌症患者中,18F-FDG PET/CT可辅助鉴别肾上腺肿块良恶性。
  • 肿瘤SUVmax与肝脏SUVmax比值>1.5时,灵敏度86.7%、特异度86.1%。
  • 作者认为18F-FDG PET/CT应推荐用于大和/或性质未定肾上腺肿块评估。

核心结论

  • 作者结论认为18F-FDG PET/CT可补充肾上腺洗脱CT用于肾上腺肿块评估,应推荐用于大和/或性质未定肾上腺肿块的评估。

研究设计与样本

  • 前瞻性多中心研究纳入87例非癌症患者的87个肾上腺肿块,其中56个肿块直径≥40 mm,31个直径<40 mm且平扫及洗脱CT密度提示性质未定。
  • 14例患者存在皮质醇增多症。
  • 以组织学为恶性诊断金标准;无病理证据者(n=23)依据12个月影像随访判断病变性质。

主要发现

  • 15个肾上腺肿块归为恶性(包括11个肾上腺皮质癌),72个归为良性。
  • 与良性病变相比,恶性病变体积更大(P=0.003)、平扫密度更高(P=0.002)、相对洗脱值更低(P=0.007)、18F-FDG摄取参数更高(P<10^-3)。

关键数值与推荐

  • 肿瘤SUVmax与肝脏SUVmax比值诊断恶性的最佳阈值为>1.5,灵敏度86.7%、特异度86.1%、阳性预测值56.5%、阴性预测值96.9%、准确率86.2%。

临床怎么用

  • 作者认为18F-FDG PET/CT可补充肾上腺洗脱CT,应推荐用于大和/或性质未定肾上腺肿块的评估。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Few prospective studies have evaluated the role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in the characterization of adrenal masses. OBJECTIVE: To assess the performance of 18F-FDG PET/CT in the malignancy diagnosis of adrenal masses in noncancer patients. DESIGN: Prospective multicenter study. MATERIAL AND METHODS: The study population consisted of 87 patients (87 adrenal masses) referred to endocrine surgeons: 56 with mass diameter ≥40 mm and 31 with a diameter <40 mm and of indeterminate nature based on unenhanced and washout CT attenuation densities. Fourteen patients had hypercortisolism. Adrenal masses were characterized by 18F-FDG PET/CT. Histology was the gold standard for the diagnosis of malignancy. In the absence of pathological proof (n = 23), the nature of the lesion was based on the 12-month imaging follow-up. RESULTS: Fifteen adrenal masses were classified as malignant (including 11 adrenocortical carcinomas) and 72 as benign. Compared with benign lesions, malignant lesions were larger in size (P = 0.003), had higher unenhanced densities (P = 0.002), lower relative washout values (P = 0.007), and higher 18F-FDG uptake parameters (P < 10-3). The optimal threshold value of (Tumor SUVmax:Liver SUVmax) the ratio for malignancy was >1.5 with sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of 86.7%, 86.1%, 56.5%, 96.9%, and 86.2%, respectively. CONCLUSIONS: Our results show that 18F-FDG PET/CT complements adrenal washout CT in the evaluation of adrenal masses and should be recommended in the evaluation of large and/or indeterminate adrenal masses.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Guerin C, Pattou F, Brunaud L, et al. Performance of 18F-FDG PET/CT in the Characterization of Adrenal Masses in Noncancer Patients: A Prospective Study. J Clin Endocrinol Metab. 2017. PMID: 28431167. doi:10.1210/jc.2017-00254

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。